Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Marston

Showing results (81-90 of 575) with videos related to

Pageof 58
Sort By:
Targeted Oncology|August 4, 2010
Targeted therapies for non-clear renal cell carcinomaEric A Singer, Gennady Bratslavsky, W Marston Linehan, et al.
Urologic Oncology|March 17, 2009
The clinical implications of the genetics of renal cell carcinomaInger Rosner, Gennady Bratslavsky, Peter A Pinto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2015
New strategies in renal cell carcinoma: targeting the genetic and metabolic basis of diseaseRamaprasad Srinivasan, Christopher J Ricketts, Carole Sourbier, et al.
Urology|September 14, 2010
Should preservable parenchyma, and not tumor size, be the main determinant of the feasibility of partial nephrectomy?Brian R Lane, Amr F Fergany, W Marston Linehan, et al.
Familial Cancer|May 25, 2013
Diagnosis and management of BHD-associated kidney cancerLambros Stamatakis, Adam R Metwalli, Lindsay A Middelton, et al.
International Immunology|January 1, 1989
Function of CD44(Pgp-1) homing receptor in human T cell precursorsA de la Hera, A Acevedo, W Marston, et al.
Cancer|November 14, 2012
Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristicsWong-Ho Chow, Brian Shuch, W Marston Linehan, et al.
Journal of Thoracic Disease|February 27, 2024
Understanding the systemic effects of intrapleural tPA and DNase by evaluating effects on coagulationThomas W Marston, Kartikeya Rajdev, Kaeli K Samson, et al.
Veterinary Immunology and Immunopathology|December 30, 1999
Structure and expression of ovine complement receptor type 2A J Young, L Dudler, K Yamaguchi, et al.
Cancer Research|June 3, 2005
Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cellsKiichiro Beppu, Katsuya Nakamura, W Marston Linehan, et al.
Pageof 58

Showing results (81-90 of 575) with videos related to

Sort By:
Pageof 58
Targeted Oncology|August 4, 2010
Targeted therapies for non-clear renal cell carcinomaEric A Singer, Gennady Bratslavsky, W Marston Linehan, et al.
Urologic Oncology|March 17, 2009
The clinical implications of the genetics of renal cell carcinomaInger Rosner, Gennady Bratslavsky, Peter A Pinto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2015
New strategies in renal cell carcinoma: targeting the genetic and metabolic basis of diseaseRamaprasad Srinivasan, Christopher J Ricketts, Carole Sourbier, et al.
Urology|September 14, 2010
Should preservable parenchyma, and not tumor size, be the main determinant of the feasibility of partial nephrectomy?Brian R Lane, Amr F Fergany, W Marston Linehan, et al.
Familial Cancer|May 25, 2013
Diagnosis and management of BHD-associated kidney cancerLambros Stamatakis, Adam R Metwalli, Lindsay A Middelton, et al.
International Immunology|January 1, 1989
Function of CD44(Pgp-1) homing receptor in human T cell precursorsA de la Hera, A Acevedo, W Marston, et al.
Cancer|November 14, 2012
Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristicsWong-Ho Chow, Brian Shuch, W Marston Linehan, et al.
Journal of Thoracic Disease|February 27, 2024
Understanding the systemic effects of intrapleural tPA and DNase by evaluating effects on coagulationThomas W Marston, Kartikeya Rajdev, Kaeli K Samson, et al.
Veterinary Immunology and Immunopathology|December 30, 1999
Structure and expression of ovine complement receptor type 2A J Young, L Dudler, K Yamaguchi, et al.
Cancer Research|June 3, 2005
Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cellsKiichiro Beppu, Katsuya Nakamura, W Marston Linehan, et al.
Pageof 58